(Q39480395)

English

Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

DNA methylation

0 references

cancer metastasis

1 reference

based on heuristic

inferred from title

author name string

Ferda Ari

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Rudolf Napieralski

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Engin Ulukaya

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Egemen Dere

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Christoph Colling

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Katja Honert

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Achim Krüger

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Marion Kiechle

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Manfred Schmitt

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cell Biochemistry & Function

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

651-659

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Chromatin, cancer and drug therapies

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Analysis of repetitive element DNA methylation by MethyLight

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Epigenomics and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

The context and potential of epigenetics in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Tracing the origins of metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Antineoplastic effects of decitabine, an inhibitor of DNA promoter methylation, in adrenocortical carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBF.1801

21 January 2018

Identifiers

10.1002/CBF.1801

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_33mnhhbbm5ab7bd7ttyvir54ce

1 reference

https://api.fatcat.wiki/v0/release/33mnhhbbm5ab7bd7ttyvir54ce

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39480395&oldid=1940923280"